 |
 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
By Preferred Stock Channel Staff, updated Wednesday, December 11, 7:19 PM
|
|||||||||||||||||||||||||||||||||||||||||||
Free AMSG Email Alerts:
Preferred Stock Offerings
| This Slide: #445 of 630 |
Slide #445. AMSURG Corp. — Preferred Stock Offering
Company:
AMSURG Corp. (AMSG)
Date announced:
6/23/2014
Shares Offered:
8,500,000
Date of Pricing:
6/26/2014
Price Per Share:
$45
Preferred Stock Offering Details:
AMSURG Corp. (NASDAQ:AMSG) today announced that it is concurrently offering 8,500,000 shares of its common stock and 1,250,000 shares of its Mandatory Convertible Preferred Stock, Series A-1, each in a separate registered public offering, subject to market and other conditions. The common stock and mandatory convertible preferred stock offerings are separate public offerings made by separate prospectus supplements. Neither offering is contingent upon the other offering or upon the consummation of the recently announced transaction between AMSURG and Sheridan Healthcare Inc. (the "Sheridan Transaction"). - updated 6/30 - AMSURG Corp. (NASDAQ:AMSG) today announced that it has priced its concurrent public offerings of 8,500,000 shares of its common stock at a public offering price of $45.00 per share and 1,500,000 shares of its 5.250% Mandatory Convertible Preferred Stock, Series A-1, at a public offering price of $100 per share. In addition, the underwriters in each respective offering have been granted a 30-day option to purchase up to an additional 1,275,000 shares of common stock and up to an additional 225,000 shares of Mandatory Convertible Preferred Stock, Series A-1. The common stock and mandatory convertible preferred stock offerings are separate public offerings made by separate prospectus supplements. Neither offering is contingent on the other offering or upon the consummation of the recently announced transaction between AMSURG and Sheridan Healthcare Inc. (the "Sheridan Transaction").
Amsurg operates in two lines of business: the operation of ambulatory surgery centers and providing outsourced physician services. Through its ambulatory services segment, Co. acquires, develops and operates ambulatory surgery centers (ASCs, surgery centers, or centers) in partnership with physicians. Through its physician services segment, Co. provides outsourced physician services in multiple specialties to hospitals, ASCs and other healthcare facilities, primarily in the areas of anesthesiology, radiology, children's services and emergency medicine. At Dec 31 2015, Co. operated 257 ASCs in 34 states and the District of Columbia in partnership with physicians.
Preferred: AMSGP
Open the AMSG Page at Preferred Stock Channel »
|
|||||||||
|
|
Open the AMSG Page at Preferred Stock Channel (in a new window) »
|
|
